The pharmaceutical world is observing a major shift in diabetes treatment with the introduction of GLP-1 transdermal devices. These patches offer a potentially more comfortable alternative to subcutaneous administrations of GLP-1 drugs, minimizing the frequency of daily needle sticks. The technology administers the medication directly through the e